Artwork

Content provided by Hall T Martin. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Hall T Martin or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Investor Connect 824: Family Office Roundtable Part 02

25:18
 
Share
 

Manage episode 478991280 series 2414821
Content provided by Hall T Martin. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Hall T Martin or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
In this episode of Investor Connect, Hall T. Martin welcomes Herbert to discuss the pivotal role family offices play within the entrepreneurial ecosystem. Herbert highlights the importance of understanding local accelerators, venture capitalists (VCs), and other funding sources in the community during the investment due diligence process. He emphasizes that co-investment requests from family offices to VCs are typically more successful than those from individual entrepreneurs, as they signify a commitment and vested interest from the family offices, thus encouraging VCs to engage more readily. Herbert also notes the unique contributions of family offices in supporting emerging managers within the venture capital space, often stepping in to fund those who have yet to build the extensive track records required by larger institutional investors like pension funds or foundations. In the latter part of the episode, Hall introduces Mark Depa of BIO Oxo, a biotech company pioneering innovative treatments for conditions like stroke. Mark pitches their leading compound, BIO 01, which is in phase two clinical trials for treating intracerebral hemorrhage, a type of hemorrhagic stroke. He explains the compound’s unique origins and mechanisms, derived from the saliva of ticks, and discusses its potential to address a significant unmet medical need. Mark also outlines the company's milestones, market potential, and funding strategy, emphasizing the strong backing and promising preliminary data that positions BIO Oxo for substantial growth and impact in the medical field. Thank you for joining us for the Startup Funding Espresso where we help startups and investors connect for funding. Let’s go startup something today. _______________________________________________________ For more episodes from Investor Connect, please visit the site at: Check out our other podcasts here: For Investors check out: For Startups check out: For eGuides check out: For upcoming Events, check out For Feedback please contact [email protected] Please , share, and leave a review. Music courtesy of .
  continue reading

2408 episodes

Artwork
iconShare
 
Manage episode 478991280 series 2414821
Content provided by Hall T Martin. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Hall T Martin or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
In this episode of Investor Connect, Hall T. Martin welcomes Herbert to discuss the pivotal role family offices play within the entrepreneurial ecosystem. Herbert highlights the importance of understanding local accelerators, venture capitalists (VCs), and other funding sources in the community during the investment due diligence process. He emphasizes that co-investment requests from family offices to VCs are typically more successful than those from individual entrepreneurs, as they signify a commitment and vested interest from the family offices, thus encouraging VCs to engage more readily. Herbert also notes the unique contributions of family offices in supporting emerging managers within the venture capital space, often stepping in to fund those who have yet to build the extensive track records required by larger institutional investors like pension funds or foundations. In the latter part of the episode, Hall introduces Mark Depa of BIO Oxo, a biotech company pioneering innovative treatments for conditions like stroke. Mark pitches their leading compound, BIO 01, which is in phase two clinical trials for treating intracerebral hemorrhage, a type of hemorrhagic stroke. He explains the compound’s unique origins and mechanisms, derived from the saliva of ticks, and discusses its potential to address a significant unmet medical need. Mark also outlines the company's milestones, market potential, and funding strategy, emphasizing the strong backing and promising preliminary data that positions BIO Oxo for substantial growth and impact in the medical field. Thank you for joining us for the Startup Funding Espresso where we help startups and investors connect for funding. Let’s go startup something today. _______________________________________________________ For more episodes from Investor Connect, please visit the site at: Check out our other podcasts here: For Investors check out: For Startups check out: For eGuides check out: For upcoming Events, check out For Feedback please contact [email protected] Please , share, and leave a review. Music courtesy of .
  continue reading

2408 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide

Listen to this show while you explore
Play